Revenue Estimates Analysis of: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI)


Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) reported the earnings of $-0.6/Share in the last quarter where the estimated EPS by analysts was $-0.54/share. The difference between the expected and actual EPS was $-0.06/share, which represents an Earnings surprise of -11.1%.

Many analysts are providing their Estimated Earnings analysis for Tokai Pharmaceuticals, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.43/share. These analysts have also projected a Low Estimate of $-0.5/share and a High Estimate of $-0.34/share.

Some buy side analysts are also providing their Analysis on Tokai Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 4 Analysts reported that the Price Target for Tokai Pharmaceuticals, Inc. might touch $2 high while the Average Price Target and Low price Target is $1.64 and $1.15 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Tokai Pharmaceuticals, Inc. got Downgrade on 26-Jul-16 where investment firm Wells Fargo Downgrade the stock from Outperform to Market Perform.

Tokai Pharmaceuticals, Inc. closed its last trading session at $1.44 with the loss of -2.08%. The Market Capitalization of the company stands at 35 Million. The Company has 52-week high of $12.93 and 52-week low of $0.98. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -10.63% where SMA50 and SMA200 are 7.58% and -70.86% respectively. The Company Touched its 52-Week High on Nov 5, 2015 and 52-Week Low on Sep 13, 2016.

The Relative Volume of the company is 0.85 and Average Volume (3 months) is 1.66 million. Tokai Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -76.5%. The Return on Equity (ROE) value stands at -85.4%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Tokai Pharmaceuticals, Inc. currently shows a Weekly Performance of -25%, where Monthly Performance is 5.22%, Quarterly performance is -73.55%, 6 Months performance is -80.22% and yearly performance percentage is -87.34%. Year to Date performance value (YTD perf) value is -83.83%. The Stock currently has a Weekly Volatility of 15.05% and Monthly Volatility of 14.58%.